This group detected fibrillary acid protein-positive (GFAP), CD45-negative CTCs in 20.6% of patients with glioblastoma and found to harbor specific aberrations of the primary tumor, including EGFR gene amplification, or chromosome insertions or deletions. Here, EGFR is linked to glioblastoma.